Search research articles
Contact Us
Filters
Showing results (131-140 of 214) with videos related to
Page
of 22
Sort By:
Journal for Immunotherapy of Cancer
|
March 22, 2019
A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia
Rosa Nguyen, Huiyun Wu, Stanley Pounds, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2011
Phase I pharmacokinetic and pharmacodynamic study of the multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in pediatric relapsed/refractory leukemia
Hiroto Inaba, Jeffrey E Rubnitz, Elaine Coustan-Smith, et al.
Journal of Cancer Survivorship : Research and Practice
|
March 26, 2026
Association of neuropathy, sarcopenia and physical function in acute lymphoblastic leukemia survivors with chemotherapy alone
Martin Kaj Fridh, Mengqi Xing, Sedigheh Mirzaei, et al.
JAMA Network Open
|
May 16, 2024
Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid Leukemia
Jatinder K Lamba, Richard Marrero, Huiyun Wu, et al.
Blood
|
September 24, 2024
Outcomes in patients with ETV6::RUNX1 or high-hyperdiploid B-ALL treated in the St. Jude Total Therapy XV/XVI studies
Katelyn Purvis, Yinmei Zhou, Seth E Karol, et al.
Nature Communications
|
May 18, 2019
A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML
Christina D Drenberg, Anang Shelat, Jinjun Dang, et al.
Cancer
|
February 7, 2014
Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia
Sima Jeha, Elaine Coustan-Smith, Deqing Pei, et al.
Clinical Pharmacology and Therapeutics
|
December 17, 2024
Clinical Actionability of the NUDT15 *4 (p.R139H) Allele and Its Association With Hispanic Ethnicity
Maud Maillard, Jenny Q Nguyen, Wenjian Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2024
Pharmacogenomic Score Effectively Personalizes Treatment of Acute Myeloid Leukemia
Richard J Marrero, Huiyun Wu, Xueyuan Cao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 29, 2019
Sorafenib Population Pharmacokinetics and Skin Toxicities in Children and Adolescents with Refractory/Relapsed Leukemia or Solid Tumor Malignancies
Hiroto Inaba, John C Panetta, Stanley B Pounds, et al.
Page
of 22
Search research articles
Search
Showing results (131-140 of 214) with videos related to
Sort By:
Page
of 22
Journal for Immunotherapy of Cancer
|
March 22, 2019
A phase II clinical trial of adoptive transfer of haploidentical natural killer cells for consolidation therapy of pediatric acute myeloid leukemia
Rosa Nguyen, Huiyun Wu, Stanley Pounds, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 20, 2011
Phase I pharmacokinetic and pharmacodynamic study of the multikinase inhibitor sorafenib in combination with clofarabine and cytarabine in pediatric relapsed/refractory leukemia
Hiroto Inaba, Jeffrey E Rubnitz, Elaine Coustan-Smith, et al.
Journal of Cancer Survivorship : Research and Practice
|
March 26, 2026
Association of neuropathy, sarcopenia and physical function in acute lymphoblastic leukemia survivors with chemotherapy alone
Martin Kaj Fridh, Mengqi Xing, Sedigheh Mirzaei, et al.
JAMA Network Open
|
May 16, 2024
Pharmacogenomics, Race, and Treatment Outcome in Pediatric Acute Myeloid Leukemia
Jatinder K Lamba, Richard Marrero, Huiyun Wu, et al.
Blood
|
September 24, 2024
Outcomes in patients with ETV6::RUNX1 or high-hyperdiploid B-ALL treated in the St. Jude Total Therapy XV/XVI studies
Katelyn Purvis, Yinmei Zhou, Seth E Karol, et al.
Nature Communications
|
May 18, 2019
A high-throughput screen indicates gemcitabine and JAK inhibitors may be useful for treating pediatric AML
Christina D Drenberg, Anang Shelat, Jinjun Dang, et al.
Cancer
|
February 7, 2014
Impact of tyrosine kinase inhibitors on minimal residual disease and outcome in childhood Philadelphia chromosome-positive acute lymphoblastic leukemia
Sima Jeha, Elaine Coustan-Smith, Deqing Pei, et al.
Clinical Pharmacology and Therapeutics
|
December 17, 2024
Clinical Actionability of the NUDT15 *4 (p.R139H) Allele and Its Association With Hispanic Ethnicity
Maud Maillard, Jenny Q Nguyen, Wenjian Yang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 30, 2024
Pharmacogenomic Score Effectively Personalizes Treatment of Acute Myeloid Leukemia
Richard J Marrero, Huiyun Wu, Xueyuan Cao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 29, 2019
Sorafenib Population Pharmacokinetics and Skin Toxicities in Children and Adolescents with Refractory/Relapsed Leukemia or Solid Tumor Malignancies
Hiroto Inaba, John C Panetta, Stanley B Pounds, et al.
Page
of 22